Tracked deals
6
6 tracked deals across 2020-2025.
Operating Company
Healthcare
McKesson Ventures
San Francisco, CA, United States
McKesson Ventures invests in and partners with innovators building and scaling healthcare businesses that support a simpler, more effective, and more efficient healthcare delivery system. It targets early and growth-stage companies and serves as a strategic conduit to McKesson’s strengths, relationships, and industry breadth.
- Focus Areas
- Digital health, Health care innovation / investing, Life sciences analytics
- Website
- ventures.mckesson.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
4 buyout · 1 addon · 1 recapitalization
McKesson Ventures Acquisition Volume by Year
Last 4 years
Supporting Data
Recent Transactions
-
- Buyer
- McKesson Corporation
- Target
- Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures)
- Seller
- Florida Cancer Specialists & Research Institute (FCS) / FCS physicians
- Industry
- Healthcare Services
- Location
- Florida, United States
- Type
- Buyout
McKesson Corporation completed the acquisition of an approximate 70% controlling interest in Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures) for about $2.49 billion. The venture was established by Florida Cancer Specialists & Research Institute (FCS), whose physicians retained an approximate 30% interest; FCS remains independently owned and joins McKesson's The US Oncology Network to strengthen community-based oncology care and expand access to clinical development and local cancer services.
-
- Buyer
- McKesson Corporation
- Target
- PRISM Vision Holdings, LLC
- Seller
- Quad-C Management, Inc.
- Industry
- Healthcare Services
- Location
- Virginia, United States
- Type
- Buyout
McKesson Corporation completed the acquisition of an approximate 80% controlling interest in PRISM Vision Holdings, LLC for about $850 million. PRISM physicians will retain an approximate 20% interest, and PRISM Vision will be consolidated within McKesson’s U.S. Pharmaceutical segment.
-
May 9, 2022
- Buyer
- Arsenal Capital Partners, McKesson Corporation
- Target
- OncoHealth
- Seller
- Baird Capital
- Industry
- Healthcare Services
- Location
- Georgia, United States
- Type
- Buyout
Arsenal Capital Partners has acquired a majority ownership stake in OncoHealth, a digital health company focused on oncology, with McKesson Corporation making a strategic minority investment. Baird Capital, the prior investor, will retain a minority equity stake; financial terms were not disclosed. The investments are intended to accelerate OncoHealth’s product innovation, expansion of oncology digital solutions, and market growth.
-
October 20, 2021
- Buyer
- Carlyle, Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund, McKesson Ventures, Northpond Ventures, Pfizer Ventures, Population Health Partners
- Target
- Saama Technologies
- Industry
- AI & Machine Learning
- Location
- California, United States
- Type
- Buyout
Global investment firm Carlyle led a strategic growth investment of up to $430 million to acquire a majority stake in Saama Technologies. A syndicate of healthcare-focused investors — including Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund, McKesson Ventures, Northpond Ventures, Pfizer Ventures and Population Health Partners — will co-invest to accelerate Saama's AI-driven Life Science Analytics Cloud and expand go-to-market and R&D capabilities.
-
March 17, 2021
- Buyer
- Clayton, Dubilier & Rice (CD&R), Merck Global Health Innovation Fund (Merck GHI), McKesson Ventures
- Target
- M2GEN
- Industry
- Healthcare Services
- Location
- Florida, United States
- Type
- Recapitalization
Clayton, Dubilier & Rice (CD&R) led a recapitalization of oncology data and informatics company M2GEN, with strategic investments from Merck Global Health Innovation Fund and McKesson Ventures. The transaction — which closed with terms undisclosed — positions CD&R as the largest shareholder and will fund growth of M2GEN's linked clinical and genomic data assets and expanded technology and informatics capabilities.
-
October 14, 2020
- Buyer
- IVX Health, Linden Capital Partners, McKesson Ventures, Health Velocity Capital, Nueterra Capital
- Target
- Precision Healthcare
- Seller
- BAI Healthcare Services, EW Healthcare Partners
- Industry
- Healthcare Services
- Location
- Tennessee, United States
- Type
- Addon
IVX Health acquired Precision Healthcare, a Nashville-based operator of 12 ambulatory infusion centers in Tennessee and northern Arkansas. The acquisition was financed with preferred equity led by Linden Capital Partners and joined by McKesson Ventures, Health Velocity Capital, and Nueterra Capital; Precision was previously a subsidiary of BAI Healthcare Services (a portfolio company of EW Healthcare Partners).
Related Acquisition Pages
Healthcare Services Buyers & Acquisitions
5 tracked deals by McKesson Ventures.
AI & Machine Learning Buyers & Acquisitions
1 tracked deal by McKesson Ventures.
Acquisitions in Florida
2 tracked deals by McKesson Ventures.
Acquisitions in California
1 tracked deal by McKesson Ventures.
Acquisitions in Georgia
1 tracked deal by McKesson Ventures.
Acquisitions in Tennessee
1 tracked deal by McKesson Ventures.
Selling a company? Get in front of buyers like McKesson Ventures
Turn tracked acquisition activity into an outreach-ready buyer list.